What You Should Know:
- A new market survey from Carta Healthcare reveals that hospital leaders are overwhelmingly rejecting fully autonomous AI in favor of "hybrid intelligence" models that pair technology with clinical expertise.
- With 62.5% of respondents citing data misinterpretation as a critical risk of "black box" systems, the industry is cementing a preference for AI that augments rather than replaces human decision-making.
The End of the "Black Box": Why Hospitals
Read More
40% of Nurses Planning to Quit: How Streamlined EHR Workflows Can Save the Profession
What You Should Know:
A new report from the KLAS Arch Collaborative reveals that the overwhelming burden of documentation is a primary driver of nurse burnout, with 40% of nurses intending to leave the profession by 2029.
- The study also highlights that meaningful progress is possible: organizations that have implemented specific strategies to streamline charting—such as eliminating redundant fields and utilizing AI—have seen dramatic improvements in nurse
Read More
Democratizing Data: How WellSky and uMed Are Bringing Clinical Trials into the Living Room
What You Should Know:
- WellSky and uMed have formed a strategic partnership to integrate clinical research opportunities directly into the workflows of home-based care providers. By combining WellSky’s network of 10,000 providers with uMed’s automated registry platform, the initiative allows patients—particularly in underserved and rural areas—to participate in national research registries without leaving their homes.
- The model is designed to generate high-quality real-world data
Read More
2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over
If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from "flashy, one-off experiments" to "top-down programs designed for measurable impact". Across the digital health landscape, executives agree that the "pilot era is ending," with the focus shifting entirely to systems that can be "governed, audited, and trusted" at scale.
The narrative for the coming year is no longer about the novelty of generative AI
Read More
PwC 2026 Outlook: Health Services M&A Poised for Rebound as AI Becomes “Core Driver” of Value
What You Should Know:
- According to PwC's 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
- The report highlights a strategic pivot among private equity investors away from reimbursement-heavy assets toward AI-enabled software and services that drive margin expansion without adding labor. With the IPO window reopening and "mega-funds" returning to offense, the winners in 2026 will be
Read More
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
- MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on "deep health" solutions that address diseases linked to environmental toxins and synthetic exposures.
- Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that move beyond symptom management
Read More
Tampa General Hospital Partners with Reimagine Care to Launch AI-Enabled Virtual Oncology Support
What You Should Know:
- Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
- The collaboration, backed by an investment from TGH Ventures, provides 24/7 symptom monitoring and triage to reduce emergency department visits and administrative burden on oncologists. This move aims to expand capacity and improve patient outcomes across Florida, a state facing 115,000 new
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know:
- Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform.
- The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips' existing portfolio.
- The strategic expansion aims to
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
